000			02029nam a2200361 4500
001			7554
010			_a9291681237
090			_a7554
100			_a20020716d2002 y0pory50 ba
101			_aeng
200			_aReport on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d2002
215			_a116 p. _cil. _d21 cm
225			_aImplemention of the joint action _v3
300			_aInformação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https://www.emcdda.org
330			_aReport on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on ketamine in accordance with Article 3 of the joint action of 16 june 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of ketamine in human medicine in the EU Member States. Use of ketamine in veterinary medicine in the EU Member States. Review of the pharmacotoxicological data on ketamine. Sociological and criminological (Europol) evidence. Public health risks - epidemiological evidence.
606			_aDROGAS ILÍCITAS _96631
606			_aSUBSTÂNCIAS PSICOTRÓPICAS _96333
606			_aCOOPERAÇÃO INTERNACIONAL _9581
606			_aSAÚDE PÚBLICA _91370
606			_aMEDICINA _91408
606			_aEUROPOL _9103050
606			_aCONSELHO DA EUROPA _96334
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA _95764
852			_jDRO320